Literature DB >> 19841562

RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience.

Ainahi Abdelhakim1, Anne Barlier, Mohamed Kebbou, Nadia Benabdeljalil, Mohammed Timinouni, Fechtali Taoufiq, Catherine Roche, Said El Antri.   

Abstract

BACKGROUND: Germline RET gene mutations are well known to be the genetic causes of multiple endocrine neoplasia type 2 (MEN2) and may be identified by genetic screening. AIM: The purpose of the present study was to screen nine MTC patients for RET sequence changes.
MATERIALS AND METHODS: In this study, our sample was composed of 30 individuals: 9 index patients with medullary thyroid carcinoma (MTC) corresponding either to 3 subjects with clinical evidence of MEN2, 6 with apparently sporadic MTC (sMTC), and 21 relatives have been investigated for RET mutations. After DNA extraction from peripheral blood leukocytes, RET exons 8, 10, 11, 13-16 and exon/intron boundaries were analyzed by direct PCR sequencing.
RESULTS: Three different known RET germline mutations in exon 11 (codon 634), p.Cys634Arg (c1900 T-->C) (de novo case), p.Cys634Phe (c1901 G-->T), p.Cys634Trp (c1902 C-->G), were detected in three individuals with MEN2 phenotype. Of the 21 relatives, 2 cases presented mutation. Among the six probands with sMTC, none was found to carry mutation. There was no difference between RET polymorphisms detected among both MEN2 and sMTC patients.
CONCLUSIONS: These preliminary data suggest that the RET mutation spectra observed in Moroccan patients with MEN2 are similar to those previously reported in other countries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841562     DOI: 10.4103/0973-1482.57126

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.

Authors:  Sara Sheikholeslami; Marjan Zarif Yeganeh; Laleh Hoghooghi Rad; Hoda Golab Ghadaksaz; Mehdi Hedayati
Journal:  Iran J Public Health       Date:  2014-02       Impact factor: 1.429

2.  Oncogenesis of Thyroid Cancer

Authors:  Enas Younis
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.